ING2 and non-small cell lung carcinoma: A study observed the loss of ING2 expression in 70 out of 120 (58.3%) NSCLC [62] (Table 1), and was more frequent in adenocarcinoma than in squamous cell carcinoma (68% and 45%, respectively).